Safety and efficacy of talquetamab in patients with relapsed and refractory multiple myeloma (RRMM) with and without renal impairment (RI)
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Laura Joiner, Oren Pasvolsky, Aimaz Afrough, Saurabh Zanwar, Rahul Banerjee, Raffaella Cassano Cassano, Mahmoud Gaballa, Kelley Julian, Ariel Grajales-Cruz, Melissa Alsina, Utkarsh Goel, Andre Corraes, Danai Dima, Masooma Rana, Hitomi Hosoya, Lekha Mikkilineni, Lindsay Fogel, Shahzad Raza, Hossam M. Ali, Aishwarya Sannareddy, Douglas Sborov, Azra Borogovac, Murali Janakiram, James Davis, Kimberly Green, Noa Biran, Hamza Hassan, Megan Herr, Leyla Shune, Evguenia Bhurtel, Shebli Atrash, Christopher Ferreri, Shonali Midha, Omar Nadeem, Omar Alexis Castaneda Puglianini, Kenneth Shain, Muhammad Bilal Abid, Peter Voorhees, Jack Khouri, Andrew Portuguese, Yi Lin, Surbhi Sidana, Doris Hansen, Krina Patel, Luciano Costa, Susan Bal, Larry Anderson
Institutions: University of Alabama at Birmingham, The University of Texas MD Anderson Cancer Center, The University of Texas Southwestern Medical Center, Mayo Clinic, Fred Hutch Cancer Center, University of Utah, Huntsman Cancer Institute, Moffitt Cancer Center, Stanford Medicine, Stanford University, Hackensack University Medical Center, Cleveland Clinic, City Of Hope National Medical Center, City of Hope, Medical University of South Carolina, Roswell Park Comprehensive Cancer Center, University of Kansas Medical Center, Levine Cancer Institute, Dana-Farber Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108457223